Figure 4
From: Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
POH synergizes with bortezomib in inducing cytotoxicity in Rec-1, but not Jeko-1 cells. (A) Viability assessed by PI staining with flow cytometric quantitation relative to controls exposed only to vehicle at various doses of bortezomib, POH, or combination of both for 24 hours. Results expressed as mean ± 1SD of triplicate wells. (B) Combination index (CI) plots generated by the computer software CalcuSyn (Biosoft, Cambridge, UK) according to the Chou-Talalay equation ("Materials and Methods") from cytotoxicity data shown in (A). Effect is equivalent to cytotoxicity where effect of 1.0 = 100% relative cytotoxicity. Synergy is present when CI < 1.0. The combination is additive when CI = 1.0, and antagonistic when CI > 1.0.